SUPCON Technology (SH:688777) Mei Ri Jing Ji Xin Wen·2025-10-24 09:39Group 1 - The core point of the article is that Zhongkong Technology (SH 688777) held its 15th meeting of the 6th board of directors on October 24, 2025, to review the proposal for the third quarter report of 2025 [1] - For the year 2024, the revenue composition of Zhongkong Technology is as follows: Chemicals 36.83%, Petrochemicals 20.28%, Oil and Gas 9.68%, Pharmaceuticals and Food 8.11%, Energy 5.85%, Others 5.79%, and Metallurgy 5.34% [1] - As of the time of reporting, Zhongkong Technology has a market capitalization of 42 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated 80 billion USD in overseas licensing this year, indicating a strong performance in the biopharmaceutical sector [1] - There is a discussion on the hot secondary market for biomedicine, while the primary market is experiencing a cooling in fundraising, highlighting a divergence in market conditions [1]